Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • iBlastoids: Reprogrammed skin cells as a Human Embryo

Understanding Allogeneic adipose-derived stem cell

New species of bacterial strains discovered at the International Space Station!

iBlastoids: Reprogrammed skin cells as a Human Embryo
  • BiotechToday
  • World

iBlastoids: Reprogrammed skin cells as a Human Embryo

bioxone March 23, 2021March 23, 2021

Devyani Goswami, Amity University Kolkata

José M. Polo, PhD, a professor of anatomy and developmental biology at Monash University, discovered a way to generate induced blastoids or iBlastoids that imitates the natural human blastoids; made up of reprogrammed skin cells. Molecular and functional assays were performed to demonstrate that the structures were blastocyst-like structures that could model several aspects of blastocyst biology. 

These iBlastoidshas an inner cell mass-like structure, with epiblast- and primitive endoderm-like cells, a blastocoel-like cavity, and a trophectoderm-like outer layer of cells; similar to a human blastocyst. Further single-cell transcriptomics confirmed the presence of epiblast-, primitive endoderm-, and trophectoderm-like cells in the iBlastoids. iBlastoids can give rise to pluripotent and trophoblast stem cells and are competent enough of modelling, in vitro.

This study was conducted to learn the early steps in human development, and some of the causes of infertility, congenital diseases in early embryos, without the use of human blastocysts. The use of human blastocyst after 14 days is considered to be unethical, hence the study was conducted with a blastocyst of 11 days. There remain certain differences between the blastocyst and iBlastoids. iBlatoids lacks the zona pellucid since they are derived from the fibroblast. 

The use of iBlastoids remains under ethical and legislative constraints, even though it promises to understand and solve the problems related to early miscarriages.

Also read:Understanding Allogeneic adipose-derived stem cell

Source:

Modelling human blastocysts by reprogramming fibroblasts into iBlastoids https://www.nature.com/articles/s41586-021-03372-y

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged blastoids developmental biology human embryo iBlastoids reprogrammed skin cells

One thought on “iBlastoids: Reprogrammed skin cells as a Human Embryo”

  1. Pingback: New species of bacterial strains discovered at the International Space Station! - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

New species of bacterial strains discovered at the International Space Station!

bioxone March 23, 2021

Ayooshi Mitra, Amity University Kolkata The International Space Station, also known as ISS, is an orbital laboratory located in low-Earth orbit (LEO) that has hosted numerous astronauts for maintenance and scientific experiments in its microgravity environment. Over the last six years, astronauts from various crews have collected samples from eight different locations on the space […]

bacterial strain

Related Post

  • BiotechToday
  • World

WORLD INTELLECTUAL PROPERTY DAY! Let’s celebrate honest hard work

bioxone April 26, 2021April 26, 2021

Camelia Bhattacharyya, Amity University Kolkata Maxine Hong Kingston once quoted, “In the time of destruction, create something” and to create is the motto of most intellectual minds. There wouldn’t have been civilizations dawning out of nowhere if the human minds were at rest and wouldn’t have thought to do something “out of the box”. But […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ConCysFind – Easing the identification of preserved AA based on phylogenetic occurrence

bioxone November 3, 2020November 3, 2020

Shrestha Dutta, Amity University Kolkata ConCysFind is a Java-based pipeline instrument that uses BioJava as a web-based tool to recognize preserved Amino acids such as cysteine, tryptophan, serine, threonine, tyrosine, and methionine, etc.  ConCysFind assesses numerous arrangements considering the proteome of 21 plant species. This model investigation aimed at Cy’s as an evolutionarily preserved target […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Moderna’s mRNA–1273 granted emergency use authorization by FDA

bioxone December 28, 2020December 28, 2020

Prama Ghosh, Amity University Kolkata The Food and Drug Administration announced granted emergency use authorization to Moderna’s mRNA–1273, it’s COVID-19 vaccine for use in individuals 18 and older Friday night, the second vaccination against the coronavirus in the United States one week after the agency authorized a similar vaccine from Pfizer and BioNTech. Moderna’s vaccine […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy